http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2015003108-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb6e37389c4c290776b2c0844c07d301
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
filingDate 2013-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a96d0232d91abb74a38c4219a654db78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c714ef8a0a7d82a77d37873cb7e4be7
publicationDate 2015-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2015003108-A
titleOfInvention METHODS OF ADMINISTRATION OF RIFAXIMINE WITHOUT PRODUCING ANTIBIOTIC RESISTANCE.
abstract Methods of administration of a composition comprising rifaximin to a subject in need thereof are provided, wherein the methods do not increase the development of rifampicin resistance to a Staphylococcus spp. Methods to reduce the development of rifampicin resistance to a Staphylococcus spp. They are also provided, which comprises administering a composition comprising rifaximin to a subject in need thereof.
priorityDate 2012-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6436173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423592648
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431847471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411809709
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135900090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57507834

Total number of triples: 21.